BANK OF AMERICA CORP /DE/ - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$238,345
+18.2%
31,737
+39.0%
0.00%
Q2 2023$201,606
+259.8%
22,832
+239.0%
0.00%
Q1 2023$56,035
+165.3%
6,735
+206.1%
0.00%
Q4 2022$21,120
+0.6%
2,200
-16.0%
0.00%
Q3 2022$21,000
-25.0%
2,620
-47.2%
0.00%
Q2 2022$28,0000.0%4,9610.0%0.00%
Q1 2022$28,000
-45.1%
4,961
-56.4%
0.00%
Q4 2021$51,000
+13.3%
11,383
+134.8%
0.00%
Q3 2021$45,000
+40.6%
4,847
+8.8%
0.00%
Q2 2021$32,000
-84.7%
4,455
-86.7%
0.00%
Q1 2021$209,000
+39.3%
33,607
+66.3%
0.00%
Q4 2020$150,000
+20.0%
20,210
-2.4%
0.00%
Q3 2020$125,000
-59.0%
20,703
-43.4%
0.00%
Q2 2020$305,000
+486.5%
36,554
+321.5%
0.00%
Q1 2020$52,000
+44.4%
8,672
-4.7%
0.00%
Q2 2019$36,000
+227.3%
9,098
+273.6%
0.00%
Q1 2019$11,000
-75.0%
2,435
-64.1%
0.00%
Q4 2018$44,000
+131.6%
6,788
+204.7%
0.00%
Q3 2018$19,000
+18.8%
2,228
+43.8%
0.00%
Q2 2018$16,000
-88.1%
1,549
-86.1%
0.00%
Q1 2018$135,00011,1320.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders